Facilitating real-time data sharing while protecting individual privacy, reducing the risk of data misuse, and enhancing public trust becomes critical as precision medicine moves forward. Sharing ...

When a biotech company announces positive Phase 3 trial results or receives FDA approval, the market reaction is often immediate and substantial. This is not just speculation. These milestones ...

As I regularly engage with pharma executives and biotech founders, a common theme inevitably arises: why is precision medicine taking so long to become a reality, and is technology to blame? There’s a ...

Given their rural isolation, toiling miles away from the coastal centers of technology and finance, it's easy to overlook the remarkable growth in productivity on the average farm. One look at a chart ...

How to Improve Cancer Patients ENrollment in Clinical Trials From rEal-Life Databases Using the Observational Medical Outcomes Partnership Oncology Extension: Results of the PENELOPE Initiative in ...

Precision medicine – the practice of taking individual variations in genetic, lifestyle and environmental factors into account when developing treatment plans – will have a strong positive impact for ...

Even if you’re one of the most precise physicists on the planet — as University of Delaware Professor Marianna Safronova is — you still will need collaborators whose skills complement your own and ...

Artificial intelligence and high-performance computing (HPC) are reshaping the data center market. The top 15 cloud companies are incorporating AI into every product and service and plan to invest a ...

Precision BioSciences (NASDAQ:DTIL) added ~6% in the premarket on Wednesday after the gene therapy developer announced initial safety and efficacy data from an early-stage trial for its Hepatitis B ...

We have finally arrived in the age of marketing where your company’s strategy around data could be described as the precision and approach that a Formula One (F1) Team takes to racing. F1 cars have ...